Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma.

Autor:	Scheithauer, W, Kornek, G V, Raderer, M, Hejna, M, Valencak, J, Miholic, J, Kovats, E, Lang, F, Funovics, J, Bareck, E, Depisch, D
Zdroj:	British Journal of Cancer. 8/1/99, Vol. 80 Issue 11, p1797. 6p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu